Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · IEX Real-Time Price · USD
2.150
+0.030 (1.42%)
At close: Jul 19, 2024, 4:00 PM
2.190
+0.040 (1.86%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $174.04 million as of July 22, 2024. Its market cap has decreased by -25.59% in one year.
Market Cap
174.04M
Enterprise Value
116.79M
1-Year Change
-25.59%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since October 18, 2019, Innate Pharma's market cap has decreased from $458.70M to $174.04M, a decrease of -62.06%. That is a compound annual growth rate of -18.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 173.00M | -23.25% |
| Dec 29, 2023 | 225.40M | -24.36% |
| Dec 30, 2022 | 298.00M | -17.31% |
| Dec 31, 2021 | 360.40M | 12.13% |
| Dec 31, 2020 | 321.40M | -33.19% |
| Dec 31, 2019 | 481.10M | 4.88% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 178.83M |
| Accuray | 178.64M |
| Metagenomi | 178.33M |
| Puma Biotechnology | 176.55M |
| Fennec Pharmaceuticals | 174.59M |
| MediWound | 172.67M |
| Acumen Pharmaceuticals | 172.43M |
| OrganiGram Holdings | 170.56M |